Profile | GDS5420 / 223289_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 384.94 | 63 |
GSM1296119 | B_lesional_pre-dose | 846.88 | 77 |
GSM1296076 | C_lesional_pre-dose | 1198.64 | 82 |
GSM1296092 | D_lesional_pre-dose | 800.74 | 75 |
GSM1296103 | E_lesional_pre-dose | 317.48 | 60 |
GSM1296078 | F_lesional_pre-dose | 1250.96 | 82 |
GSM1296107 | G_lesional_pre-dose | 839.39 | 77 |
GSM1296109 | H_lesional_pre-dose | 501.12 | 67 |
GSM1296080 | I_lesional_pre-dose | 215.92 | 55 |
GSM1296090 | J_lesional_pre-dose | 974.36 | 78 |
GSM1296074 | K_lesional_pre-dose | 1016.95 | 79 |
GSM1296111 | L_lesional_pre-dose | 1175.76 | 82 |
GSM1296099 | M_lesional_pre-dose | 502.56 | 67 |
GSM1296086 | O_lesional_pre-dose | 672.22 | 73 |
GSM1296117 | P_lesional_pre-dose | 805.18 | 76 |
GSM1296113 | Q_lesional_pre-dose | 913.2 | 78 |
GSM1296096 | R_lesional_pre-dose | 562.29 | 70 |
GSM1296105 | S_lesional_pre-dose | 384.08 | 63 |
GSM1296098 | T_lesional_pre-dose | 268.72 | 57 |
GSM1296101 | U_lesional_pre-dose | 428.4 | 65 |
GSM1296121 | V_lesional_pre-dose | 588.85 | 71 |
GSM1296088 | W_lesional_pre-dose | 588.16 | 70 |
GSM1296082 | X_lesional_pre-dose | 1216.06 | 82 |
GSM1296115 | Y_lesional_pre-dose | 1168.89 | 82 |
GSM1296084 | Z_lesional_pre-dose | 545.1 | 69 |
GSM1296072 | B_lesional_day8 | 547.58 | 69 |
GSM1296069 | L_lesional_day8 | 803.1 | 76 |
GSM1296071 | P_lesional_day8 | 512.49 | 67 |
GSM1296070 | Y_lesional_day8 | 919.87 | 78 |
GSM1296073 | V_lesional_day8 | 1090.04 | 81 |
GSM1296034 | A_lesional_day15 | 93.31 | 39 |
GSM1296041 | G_lesional_day15 | 1412.87 | 84 |
GSM1296035 | R_lesional_day15 | 418.32 | 64 |
GSM1296038 | U_lesional_day15 | 609.81 | 71 |
GSM1296047 | B_lesional_day15 | 414.51 | 64 |
GSM1296039 | E_lesional_day15 | 882.01 | 77 |
GSM1296042 | H_lesional_day15 | 835.78 | 76 |
GSM1296043 | L_lesional_day15 | 695.61 | 73 |
GSM1296037 | M_lesional_day15 | 150.56 | 47 |
GSM1296046 | P_lesional_day15 | 705.36 | 73 |
GSM1296044 | Q_lesional_day15 | 605.19 | 71 |
GSM1296045 | Y_lesional_day15 | 729.97 | 74 |
GSM1296025 | C_lesional_day15 | 197.54 | 53 |
GSM1296033 | D_lesional_day15 | 338.69 | 61 |
GSM1296027 | I_lesional_day15 | 167.99 | 51 |
GSM1296032 | J_lesional_day15 | 232.46 | 55 |
GSM1296024 | K_lesional_day15 | 166.04 | 50 |
GSM1296031 | W_lesional_day15 | 219.15 | 53 |
GSM1296028 | X_lesional_day15 | 275.92 | 58 |
GSM1296029 | Z_lesional_day15 | 214.04 | 53 |
GSM1296026 | F_lesional_day15 | 495.21 | 68 |
GSM1296030 | O_lesional_day15 | 302.65 | 60 |
GSM1296040 | S_lesional_day15 | 397.18 | 63 |
GSM1296036 | T_lesional_day15 | 176.11 | 49 |
GSM1296048 | V_lesional_day15 | 888.93 | 77 |
GSM1296059 | A_lesional_day43 | 445.96 | 66 |
GSM1296066 | G_lesional_day43 | 944.22 | 79 |
GSM1296060 | R_lesional_day43 | 436.41 | 65 |
GSM1296063 | U_lesional_day43 | 1124.11 | 81 |
GSM1296064 | E_lesional_day43 | 1105.5 | 81 |
GSM1296067 | H_lesional_day43 | 399.29 | 63 |
GSM1296062 | M_lesional_day43 | 261.34 | 56 |
GSM1296068 | Q_lesional_day43 | 531.32 | 68 |
GSM1296050 | C_lesional_day43 | 399.73 | 64 |
GSM1296057 | D_lesional_day43 | 343.51 | 61 |
GSM1296052 | I_lesional_day43 | 172.76 | 51 |
GSM1296054 | J_lesional_day43 | 103.91 | 41 |
GSM1296049 | K_lesional_day43 | 225.07 | 55 |
GSM1296055 | W_lesional_day43 | 275.11 | 57 |
GSM1296053 | X_lesional_day43 | 127.38 | 45 |
GSM1296058 | Z_lesional_day43 | 434.72 | 65 |
GSM1296051 | F_lesional_day43 | 574.2 | 70 |
GSM1296056 | O_lesional_day43 | 606.98 | 71 |
GSM1296065 | S_lesional_day43 | 738.77 | 74 |
GSM1296061 | T_lesional_day43 | 192.3 | 51 |
GSM1296095 | A_non-lesional_pre-dose | 490.14 | 68 |
GSM1296120 | B_non-lesional_pre-dose | 373.54 | 62 |
GSM1296077 | C_non-lesional_pre-dose | 175.83 | 51 |
GSM1296093 | D_non-lesional_pre-dose | 207.33 | 52 |
GSM1296104 | E_non-lesional_pre-dose | 520.7 | 69 |
GSM1296079 | F_non-lesional_pre-dose | 307.31 | 60 |
GSM1296108 | G_non-lesional_pre-dose | 473.74 | 67 |
GSM1296110 | H_non-lesional_pre-dose | 474.21 | 66 |
GSM1296081 | I_non-lesional_pre-dose | 107.88 | 44 |
GSM1296091 | J_non-lesional_pre-dose | 570.97 | 70 |
GSM1296075 | K_non-lesional_pre-dose | 552.27 | 70 |
GSM1296112 | L_non-lesional_pre-dose | 449.8 | 65 |
GSM1296100 | M_non-lesional_pre-dose | 273.74 | 57 |
GSM1296087 | O_non-lesional_pre-dose | 256.9 | 58 |
GSM1296118 | P_non-lesional_pre-dose | 476.25 | 66 |
GSM1296114 | Q_non-lesional_pre-dose | 595.64 | 70 |
GSM1296097 | R_non-lesional_pre-dose | 397.75 | 64 |
GSM1296106 | S_non-lesional_pre-dose | 364.56 | 62 |
GSM1296102 | U_non-lesional_pre-dose | 229.77 | 53 |
GSM1296122 | V_non-lesional_pre-dose | 406.27 | 64 |
GSM1296089 | W_non-lesional_pre-dose | 232.27 | 54 |
GSM1296083 | X_non-lesional_pre-dose | 180.18 | 51 |
GSM1296116 | Y_non-lesional_pre-dose | 607.4 | 71 |
GSM1296085 | Z_non-lesional_pre-dose | 158.51 | 49 |